Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective

J Conniff, A Evensen - The Journal of the American Board of …, 2016 - Am Board Family Med
Until recently there have been few primary care office-based strategies to reduce the
transmission of HIV. In May 2014 the Centers for Disease Control and Prevention published …

What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review

D Krakower, KH Mayer - Annals of internal medicine, 2012 - acpjournals.org
As HIV prevalence climbs globally, including more than 50 000 new infections per year in
the United States, we need more effective HIV prevention strategies. The use of …

[HTML][HTML] Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care

A Silapaswan, D Krakower, KH Mayer - Journal of general internal …, 2017 - Springer
Since FDA approval of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, attention
has been focused on PrEP implementation. The CDC estimates that 1.2 million US adults …

HIV preexposure prophylaxis: a review

J Riddell, KR Amico, KH Mayer - Jama, 2018 - jamanetwork.com
Importance About 40 000 Americans and 2 million people worldwide are newly infected with
HIV each year. The combination antiretroviral regimen, tenofovir disoproxil fumarate …

[HTML][HTML] State of the art review: Recent advances in PrEP for HIV

M Desai, N Field, R Grant… - BMJ (Clinical research ed …, 2017 - ncbi.nlm.nih.gov
Abstract Pre-exposure prophylaxis (PrEP), the use of antiretroviral medications by HIV-
uninfected individuals to prevent acquisition of HIV, represents a promising prevention …

HIV preexposure prophylaxis—the role of primary care clinicians in ending the HIV epidemic

J Khalili, RJ Landovitz - JAMA internal medicine, 2020 - jamanetwork.com
A global human immunodeficiency virus (HIV) epidemic persists despite data to support
multiple effective and safe tools that prevent HIV transmission and acquisition. Human …

Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?

JW Curran, RA Crosby - American Journal of Preventive Medicine, 2013 - ajpmonline.org
The US Food and Drug Administration (FDA) has approved the use of Truvada®(a fıxed-
dose combination of emtricitabine and tenofovir disoproxil fumarate) as pre-exposure …

Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement

DK Owens, KW Davidson, AH Krist, MJ Barry… - Jama, 2019 - jamanetwork.com
Importance An estimated 1.1 million individuals in the United States are currently living with
HIV, and more than 700 000 persons have died of AIDS since the first cases were reported …

Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP

L Turner, A Roepke, E Wardell, AM Teitelman - Journal of the Association of …, 2018 - Elsevier
Oral preexposure prophylaxis (PrEP) has been proven to be a safe and effective means of
preventing HIV. The purpose of our literature review was to examine primary care provider …

Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force

R Chou, C Evans, A Hoverman, C Sun, T Dana… - Jama, 2019 - jamanetwork.com
Importance Effective prevention strategies for HIV infection are an important public health
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …